Insider: Kewalramani Reshma CEO & President - VERTEX PHARMACEUTICALS INC / MA
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 110,258 | 0 | 110,258 |
| Value | $42,104,222.46 | $0.00 | $42,104,222.46 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 08/06/2025 | AAP | 4,290 | Direct | COM | $389.08 | $1,669,153.20 | 110,258 |
| 08/06/2025 | AAP | 5,710 | Direct | COM | $389.95 | $2,226,614.50 | 115,968 |
| 11/08/2024 | DDS | 15,198 | Direct | COM | $515.00 | $7,826,970.00 | 75,772 |
| 07/30/2024 | DDS | 15,202 | Direct | COM | $505.00 | $7,677,010.00 | 90,970 |
| 05/24/2024 | DDS | 1,565 | Direct | COM | $457.00 | $715,205.00 | 121,374 |
| 05/20/2024 | DDS | 15,202 | Direct | COM | $447.00 | $6,795,294.00 | 121,374 |
| 12/15/2023 | DDS | 17,135 | Direct | COM | $407.00 | $6,973,945.00 | 108,711 |
| 12/13/2023 | DDS | 5,098 | Direct | COM | $397.00 | $2,023,906.00 | 108,711 |
| 11/13/2023 | DDS | 5,097 | Direct | COM | $377.00 | $1,921,569.00 | 113,809 |
| 07/17/2023 | DDS | 7,828 | Direct | COM | $355.00 | $2,778,940.00 | 118,906 |
| 04/27/2023 | DDS | 1,611 | Direct | COM | $338.69 | $545,629.59 | 128,358 |
| 04/27/2023 | DDS | 1,668 | Direct | COM | $339.43 | $566,169.24 | 126,690 |
| 04/27/2023 | DDS | 38 | Direct | COM | $340.19 | $12,927.22 | 126,652 |
| 01/25/2023 | DDS | 10,000 | Direct | COM | $315.05 | $3,150,500.00 | 89,598 |
| 08/15/2022 | DDS | 11,689 | Direct | COM | $305.06 | $3,565,846.34 | 99,598 |
| 06/24/2022 | DDS | 11,689 | Direct | COM | $291.30 | $3,405,005.70 | 111,153 |
| 08/19/2021 | AAP | 5,757 | Direct | COM | $195.14 | $1,123,420.98 | 69,511 |
| 08/19/2021 | AAP | 4,243 | Direct | COM | $196.34 | $833,070.62 | 73,754 |
| 08/06/2020 | DDS | 870 | Direct | COM | $270.36 | $235,213.20 | 27,677 |
| 08/06/2020 | DDS | 152 | Direct | COM | $269.11 | $40,904.72 | 28,547 |
| 08/06/2020 | DDS | 471 | Direct | COM | $271.42 | $127,838.82 | 27,206 |
| 08/06/2020 | DDS | 487 | Direct | COM | $272.76 | $132,834.12 | 26,719 |
| 08/06/2020 | DDS | 93 | Direct | COM | $273.27 | $25,414.11 | 26,626 |
| 05/15/2020 | DDS | 9 | Direct | COM | $280.47 | $2,524.23 | 26,701 |
| 05/15/2020 | DDS | 7 | Direct | COM | $279.70 | $1,957.90 | 26,710 |
| 1 2 3 Next Last You are at page 1 of 3 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research